No abstract

No abstract

Arsha (Piles) is the one of the most common disease encountered in clinical and surgical practice. Arsha incidence increases with advancing age, at least 50% of people over the age of 50 years have some degree of haemorrhoidal symptoms. In this study an attempt has been made to treat the “disease” with Chirabilwadi quatha (Panartha) and Kaseesadi thaila (Sthanika abhyanga). Total thirty patients were selected by simple randomized method and allocated into three groups called Group A, B, C. Each group had ten patients. Group A. treated with Chirabilwadi quatha(Panartha), Group B. treated with Kaseesadi thaila and Group C. treated with combination of Chirabilwadi quatha and Kaseesadi thaila. Total study period was nighty days in that thirty days was treatment and sixty days was fallow-up. The effect of treatment was observed both in subjective symptoms and objective parameters. Non significant, Significant and highly significant results were observed in subjective parameters, objective parameters and overall in all three groups.

Dilated cardiomyopathy (DCM) is known to have ventricular dilatation and dysfunction in  myocardium. Primary carnitine deficiency (PCD) is a not common but a reversible autosomal recessive phenomenon with supplementation of carnitine. Case presentation- 11-month male child was brought with complain of fever, cough, cold since 7 days and increased work of breathing for 15 days.  2 D echo was done suggestive of dilated cardiomyopathy. His initial investigations; chest Xray revealed significant cardiomegaly electrocardiography, (ECG) showed prolonged QT interval fraction. Patient was treated with syrup carnitine syrup empirically, as there is no way to determine a fatty acid oxidation profile. Repeated 2D echocardiogram (2 D ECHO) was suggestive of recovery. Conclusions: Carnitine deficiency could be the cause of  cardiomyopathy and so treatment of carnitine supplementation can be considered empirically to avoid life-threatening complication related to cardiomyopathy.